News

Shareholders in Wise, a rare U.K. tech success, voted in favor of moving its main stock listing to New York and extending dual-class shares by a decade. The company will begin with five potential ...
A lone gunman carrying an assault-style rifle opened fire at an office building in midtown Manhattan on Monday evening, ...
Bristol Myers Squibb is taking a strategic leap, offloading five immunology assets, including three in clinical stages, to a ...
Dow Jones Top Company Headlines at 11 PM ET: Whirlpool Cuts Dividend, Full-Year Profit Guidance as Tariffs Hurt Quarterly Results | Procter ... Whirlpool Cuts Dividend, Full-Year Profit Guidance as ...
New Yorkers: there is an active shooter investigation taking place in Midtown right now. Please take proper safety ...
A police officer and one other person were shot at an office skyscraper in midtown Manhattan Monday evening, according to law ...
Flashpoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision-engineered structural ...
Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...
Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...
Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...
The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...